ArticleCell discovery2020
A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.
Adam M Burgoyne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleCell discovery2020
Adam M Burgoyne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.